Frailty screening tools in elderly patients with metastatic castration-resistant prostate cancer treated with docetaxel and without prior chemotherapy. FRAGDOC
OBSERVATIONAL STUDY WITH PROSPECTIVE FOLLOW-UP DRUGS
Clinical trial information
- Promoter: SPANISH GENITOURINARY ONCOLOGY GROUP (SOGUG)
- Execution start: 03/09/2021
- End of execution: 30/06/2024
- PI: RAQUEL LUQUE CARO